The cost of premature death from cancer attributable to alcohol: Productivity losses in Europe in 2018 |
| |
| Affiliation: | 1. Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France;2. Department of Applied and Public Economics, and Political Economy, Complutense University of Madrid, Madrid, Spain;3. Population Health Sciences Institute, Newcastle University Centre for Cancer, Newcastle Upon Tyne, United Kingdom;4. EPIUnit-Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal;5. Laboratório Para a Investigação Integrativa e Translacional em Saúde Populacional (ITR), Porto, Portugal;6. Departamento de Ciências da Saúde Pública e Forenses e Educação Médica, Faculdade de Medicina da Universidade do Porto, Porto, Portugal;1. Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada;2. Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada;3. Department of Surgery, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB, Canada;1. Department of Social Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan;2. Cancer Control Center, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-ku, Osaka 541-8567, Japan;3. Institute for Global Health Policy Research Center, Bureau of International Health Cooperation, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku-ku, Tokyo 162-8655, Japan;1. Department of Mathematics and Statistics, Sam Houston State University, Huntsville, TX, USA;1. CONACYT - Instituto Nacional de Cancerología, Mexico City, Mexico;2. Dirección de Investigación, Hospital General de México “Dr. Eduardo Liceaga”, Mexico City, Mexico;3. Dirección de Investigación, Instituto Nacional de Cancerología, Mexico City, Mexico;4. Departamento de Tumores Mamarios, Instituto Nacional de Cancerología, Mexico City, Mexico;5. Servicio de Oncología, Hospital General de México “Dr. Eduardo Liceaga”, Mexico City, Mexico;6. Departmento de Tumores Ginecológicos, Instituto Nacional de Cancerología, Mexico City, Mexico;7. Departmento de Tumores Urológicos, Instituto Nacional de Cancerología, Mexico City, Mexico;8. Servicio de Urología, Hospital General de México “Dr. Eduardo Liceaga”, Mexico City, Mexico;9. Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México and Instituto Nacional de Cancerología, Mexico City, Mexico;1. Unit of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark;2. Unit of Diet, Cancer and Health, Danish Cancer Society Research Center, Copenhagen, Denmark;3. Statistics and Data Analysis, Danish Cancer Society Research Center, Copenhagen, Denmark;4. Department of Gynecology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark;1. Johns Hopkins Medicine, Department of Dermatology, Baltimore, MD, USA;2. University of Texas Southwestern Medical Center, Department of Dermatology, Dallas, TX, USA;3. Case Western Reserve University School of Medicine/University Hospitals Cleveland Medical Center, Department of Dermatology, Cleveland, OH, USA |
| |
| Abstract: | BackgroundMore than 1.9 million people die from cancer each year in Europe. Alcohol use is a major modifiable risk factor for cancer and poses an economic burden on society. We estimated the cost of productivity lost due to premature death (under 65 years of age) from alcohol-attributable cancer in the European Union (EU) plus Iceland, Norway, Switzerland, and the United Kingdom (UK) in 2018.MethodsWe estimated cancer deaths attributable to alcohol using a Levin-based population attributable fractions method and cancer deaths in 2018 from the Global Cancer Observatory. Lost productivity was estimated for all alcohol-attributable cancer deaths by sex, cancer site, and country. Productivity losses were valued using the human capital approach.ResultsAn estimated 23,300 cancer deaths among people aged less than 65 in the EU plus Iceland, Norway, Switzerland and the UK in 2018 were attributable to alcohol (18,200 males, 5100 females). This equated to €4.58 billion in total productivity losses in the region and 0.027 % of the European Gross Domestic Product (GDP). The average cost per alcohol-attributable cancer death was €196,000. Productivity lost to alcohol-attributable cancer per capita was highest in Western Europe. Hungary, Romania, Slovakia, Latvia, Lithuania, and Portugal had the highest rate of premature mortality from alcohol-attributable cancer and the highest productivity lost as a share of national GDP.ConclusionOur study provides estimates of lost productivity from alcohol-attributable cancer death in Europe. Cost-effective strategies to prevent alcohol-attributable cancer deaths could result in economic benefits for society and must be prioritised. |
| |
| Keywords: | Productivity loss Alcohol Cancer Premature mortality Human capital |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
